Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial
Crossref DOI link: https://doi.org/10.1007/s00277-016-2648-4
Published Online: 2016-03-30
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
González-Barca, E.
,
Canales, M.
Salar, A.
Ferreiro-Martínez, J. J.
Ferrer-Bordes, S.
García-Marco, J. A.
Sánchez-Blanco, J. J.
García-Frade, J.
Peñalver, J.
Bello-López, J. L.
Sancho, J. M.
Caballero, D.
License valid from 2016-03-30